Carbamazepine

Carbamazepine

Nom du produit Carbamazepine
Numéro CAS 298-46-4
Formule moléculaire C15H12N2O
Poids moléculaire 236.27 g/mol
Apparence Poudre cristalline blanche à blanc cassé
Essai (HPLC) 98.0% – 102.0%
Point de fusion 190 – 193 °C
Perte au séchage ≤ 0,5%
Résidu au feu ≤ 0,11 TP3T
Métaux lourds ≤ 20 ppm
Solubilité Slightly soluble in water; soluble in ethanol, acetone, chloroform
Colis 25 kg fiber drum with double polyethylene bags

Besoin d'aide ? Contacter notre équipe

Carbamazepine Structure

Synonymes : 5H-Dibenz[b,f]azepine-5-carboxamide, 5-Carbamoyl-5H-dibenz[b,f]azepine, Carbamazepinum, CBZ, Biston, Finlepsin, Tegretol

Carbamazepine remains a cornerstone in the treatment of epilepsy and bipolar disorder, with steady demand from pharmaceutical manufacturers worldwide. Its established efficacy and favorable cost profile keep it a preferred API for generic formulations, especially in emerging markets where access to affordable anticonvulsants is critical.

This dibenzazepine carboxamide derivative is synthesized through a multi-step process from iminodibenzyl, yielding a white to off-white crystalline powder. It is practically insoluble in water but dissolves readily in organic solvents such as ethanol and acetone, a property that influences formulation strategies for both immediate and extended-release dosage forms.

LyvBio supplies Carbamazepine that meets or exceeds pharmacopeial standards, including USP, EP, and BP. With assay typically between 98.0% and 102.0% on a dried basis, our material ensures consistent potency for tablet and suspension manufacturing. Each batch is thoroughly tested for impurities, residual solvents, and heavy metals to support regulatory submissions.

Présentation et composition du produit

Carbamazepine is a synthetic dibenzazepine derivative with the molecular formula C15H12N2O and a molecular weight of 236.27 g/mol. It is structurally related to tricyclic antidepressants but functions primarily as a sodium channel blocker, reducing neuronal hyperexcitability.

The API is available in various polymorphic forms, with the triclinic form being the most stable and commonly used in solid dosage forms. Our production process is tightly controlled to consistently deliver the desired polymorph, ensuring predictable dissolution and bioavailability.

Principales applications

  • Epilepsy treatment: Indicated for partial seizures, generalized tonic-clonic seizures, and mixed seizure patterns.
  • Bipolar disorder: Used as a mood stabilizer to prevent manic and depressive episodes.
  • Trigeminal neuralgia: First-line therapy for the sharp, shooting pain associated with this condition.
  • Off-label uses: Sometimes prescribed for neuropathic pain, alcohol withdrawal, and certain psychiatric disorders.
  • Recherche: Employed in studies investigating sodium channel function and anticonvulsant mechanisms.

Qualité et normes

Paramètre Spécifications
Essai (HPLC) 98.0% – 102.0%
Perte au séchage ≤ 0,5%
Métaux lourds ≤ 20 ppm
Résidu au feu ≤ 0,11 TP3T
Limites microbiologiques Nombre total de bactéries aérobies ≤ 1 000 UFC/g ; levures et moisissures ≤ 100 UFC/g ; absence d'E. coli

Emballage et approvisionnement

  • Emballage: 25 kg fiber drums with double polyethylene liners, or as per customer request.
  • Quantité minimale de commande: 25 kg
  • Délai de livraison: 3 à 5 jours ouvrés (articles en stock)
  • Documentation: COA, MSDS, TDS, and regulatory support available upon request.

Demande de devis

RESTEZ EN CONTACT

Demande de devis

Notre adresse

Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China

✅ ×